The uncertainty of copy number variants: pregnancy decisions and clinical follow up

Panlai Shi,Hongbin Liang,Yaqin Hou,Duo Chen,Huanan Ren,Conghui Wang,Yanjie Xia,Da Zhang,Don Leigh,Xiangdong Kong,David S. Cram

DOI: https://doi.org/10.1016/j.ajog.2023.01.022

IF: 9.8

2023-01-01

American Journal of Obstetrics and Gynecology

Abstract:BACKGROUND: Next generation sequencing for copy number variants is often used as a follow-up investigation of unusual fetal ultrasound results and is capable of detecting CNVs with a resolution of ∼0.1 Mb. In a prenatal setting, observation and subsequent management of pregnancies with a fetal variant of uncertain significance (VUS) remains problematic for counselling.OBJECTIVE: To follow the decision-making processes of pregnancies identified with a fetal VUS and prospectively assess CNV interpretations and implications under the newer 2020 American College of Medical Genetics and Genomics (ACMG) guidelines.STUDY DESIGN: In a single prenatal unit, prospective chromosome testing using copy number variation sequencing for 8030 fetuses with unexpected noninvasive findings identified 139 pregnancies with a CNV classified as a VUS according to the 2015 ACMG guidelines current at the time. Parent-of-origin testing was subsequently performed to determine if the CNV was inherited or de novo. All couples were offered specialized genetic counselling to assist in pregnancy management decisions. For the continued pregnancies that reached term, newborns were clinically assessed for evidence of any disease at 0-10 months and/or between 2-4 years of age.RESULTS: Of the 139 VUS found, most (78%) were inherited with no evidence of disease in the carrier parent. Based on primary ultrasound findings combined with results from non-invasive prenatal screening tests, most inherited VUS pregnancies were continued whereas most pregnancies involving de novo VUS were terminated. From clinical follow-up of the 113 livebirths, only 5 showed any evidence of a phenotype that was not apparently related to the original VUS. Prospective reanalysis of the 139 VUS using recent 2020 ACMG guidelines changed the status of 24 VUS with 15 reclassified as benign and 9 regraded to pathogenic. However, the 5 children born with an inherited VUS reclassified as pathogenic showed no evidence of a disease phenotype on clinical follow up.CONCLUSIONS: The severity of fetal ultrasound findings combined with results from parent-of-origin testing were the key drivers in pregnancy management decisions for patients. Based on birth outcomes from continued pregnancies, most VUS proved to be apparently benign in nature and potentially of low risk of an adverse disease outcome. There was a discordance rate of 17% for VUS scoring between the 2015 and 2020 ACMG guidelines for defining a VUS suggesting that difficulties remain for predicting true pathogenicity. Nonetheless, with increasing knowledge of population CNV polymorphisms, and a more complete assessment for alternative genetic causes, patients having prenatal assessments should feel less anxious when a fetal VUS is identified.

obstetrics & gynecology